National Center for Functional Glycomics (NCFG)

Harvard Career Development Program in Translational Glycobiology (ProTG): Bridging Glycoscience and Clinical Medicine (1K12HL14195301)

October 09, 2018

NOTE- This is an annually recurring career development award.

Click Here to view details about the K12HL14195301 grant at the NIHRePORTER Site.

There are four main macromolecules of nature...

NHLBI funding leads to promising drug candidate to prevent sickle cell pain

April 14, 2018

SBIR funding by the NHLBI to Selexys results in the development of crizanlizumab. Selexys was founded in 2002 by Rodger (Rod) McEver, M.D., Richard Cummings, Ph.D., and Rick Alvarez, M.B.A. Read...

Deadline for Sialoglyco 2018 extended!

March 16, 2018

Dear Glycoscientists:

The deadline for submission of poster abstracts to the 2018 conference on Sialic Acids has been extended to Friday March 30th. This biennial conference is being held May 10...

Assessing antibodies made against complex sugars on cells leads to identification of new biomarkers for variety of diseases.

February 13, 2018

New technology enables identification of biomarkers for a wide range of diseases. Read more here.

Save the Date for GlycoCom 2018 and Human Glycome Project meeting

January 29, 2018

October 3-6, 2018 in Dubrovnik, Croatia

www.glycocom.net (website still in development, check back soon!)

Subscribe to News

Follow Us On

News

Harvard Career Development Program in Translational Glycobiology (ProTG): Bridging Glycoscience and Clinical Medicine (1K12HL14195301)

NHLBI funding leads to promising drug candidate to prevent sickle cell pain

Deadline for Sialoglyco 2018 extended!

Assessing antibodies made against complex sugars on cells leads to identification of new biomarkers for variety of diseases.

Save the Date for GlycoCom 2018 and Human Glycome Project meeting

Address